4.750USD0.00%Mkt Cap: 515.71M USDP/E: —Last update: 2026-05-22
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to h…
Industry Peers
Health Information Services25.85BUSDP/E 29.1
11.66BUSDP/E 78.1
8.39BUSD—
7.49BSEKP/E 33.5
7.35BUSDP/E 35.7
5.05BTRYP/E 27.0
4.13BUSD—
3.79BUSDP/E 29.5
Indicators:|
Key Statistics
Company
Market Cap515.71M USD
Enterprise Value240.47M USD
Revenue (TTM)588.02M USD
Gross Profit308.42M USD
Net Income (TTM)-86.46M USD
Revenue/Share5.246 USD
Last Price4.750 USD
Fiscal Year EndDec 2022
MR QuarterSep 2022
Employees2.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)16.34
PEG1.95
EV/EBITDA4.65
EV/Revenue0.41
P/S0.88
P/B0.49
EPS (TTM)-0.18
EPS (Forward)0.29
52W Range
3.00058% of range6.000
52W High6.000 USD
52W Low3.000 USD
Profitability
Gross Margin52.45%
Oper. Margin16.59%
EBITDA Margin8.80%
Profit Margin-14.70%
ROE-8.50%
ROA-5.75%
Growth
Revenue Growth5.00%
Earnings Growth-1.80%
Cash Flow & Leverage
Operating CF115.56M USD
CapEx (TTM)32.27M USD
FCF Margin20.63%
FCF Yield23.53%
Net Debt-273.79M USD
Net Debt/EBITDA-5.29
Balance Sheet
Debt/Equity0.22
Current Ratio2.95
Quick Ratio2.70
Book Value/Sh9.593 USD
Cash/Share4.550 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateOct 7, 2008
Pay DateOct 17, 2008
Analyst Consensus
Rating—
Target (Mean)5.833 USD
Target Range4.500 USD – 8.000 USD
# Analysts3
Ownership
Shares Out.108.80M
Float81.43M
Insiders5.04%
Institutions58.03%
Short Interest
Short Ratio3.9d
Shares Short8.13M
Short (prev mo.)9.43M
Technical
SMA 504.572 (+3.9%)
SMA 2004.683 (+1.4%)
Beta0.52
S&P 52W Chg28.31%
Avg Vol (30d)32.69K
Avg Vol (10d)18.94K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—